In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp [PDF]
, 2002 We investigated the in vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine, against Aspergillus spp.
Warn, P. A. +4 more
core +1 more source
Discover ChemistryThe present manuscript demonstrated an efficient microwave assisted Multicomponent reaction approach in modifying the existing drug 5-fluorocytosine (Flucytosine).
Pratibha Shukla +2 more
doaj +1 more source
Clinical efficacy of flucytosine on urinary candidiasis [PDF]
, 1988 An antifungal agent (Flucytosine) was used to treat urinary candidiasis in 9 patients who had an indwelling catheter and developed fungal colony counts greater than 10(4).
安本, 亮二 +7 more
core
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. [PDF]
, 2008 BACKGROUND: The standard therapy for human immunodeficiency virus (HIV)-associated cryptococcal meningitis of amphotericin B (AmB; 0.7 mg/kg per day) plus flucytosine frequently takes >2 weeks to sterilize the cerebral spinal fluid, and acute mortality ...
Harrison, Thomas +17 more
core +1 more source
Medical Mycology Case Reports, 2014 A patient with Candida spondylitis failed two weeks of fluconazole combined with caspofungin, and the infection relapsed despite six weeks of liposomal amphotericin B followed by two months of fluconazole.
Line Storm +4 more
doaj +1 more source
Frontiers in Microbiology, 2013 Opportunistic Candida species often have to cope with inhibitory concentrations of acetic acid, in the acidic environment of the vaginal mucosa. Given that the ability of these yeast species to tolerate stress induced by weak acids and antifungal drugs ...
Catarina eCosta +9 more
doaj +1 more source
MIC range (μg/mL) of LIF 12560 and LIF-E10 against amphotericin B, 5-flucytosine, fluconazole, itraconazole and voriconazole. [PDF]
, 2016 MIC range (μg/mL) of LIF 12560 and LIF-E10 against amphotericin B, 5-flucytosine, fluconazole, itraconazole and voriconazole.
Isabela Haddad Peron (3154302) +6 more
core +1 more source
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans. [PDF]
, 1999 Treatment failures can occur in AIDS patients infected with Cryptococcus neoformans, despite aggressive antifungal therapy. Combination regimens with additive or synergic drugs could provide additional options for treating cryptococcosis.
GIACOMETTI, Andrea +6 more
core
Antifungal Susceptibilities of Cryptococcus neoformans
Emerging Infectious Diseases, 2004 Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from
Lennox K. Archibald +11 more
doaj +1 more source
A Flucytosine-Responsive Mbp1/Swi4-Like Protein, Mbs1, Plays Pleiotropic Roles in Antifungal Drug Resistance, Stress Response, and Virulence of Cryptococcus neoformans [PDF]
, 2012 Cryptococcosis, caused by the basidiomycetous fungus Cryptococcus neoformans , is responsible for more than 600,000 deaths annually in AIDS patients. Flucytosine is one of the most commonly used antifungal drugs for its treatment,
Joseph Heitman +21 more
core +2 more sources